{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:34:43Z","timestamp":1793133283402,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline Plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaci.2026.08.029","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:52:02Z","timestamp":1790610722000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mepolizumab long-term remodeling effect in severe asthma responders: The MESILICO study"],"prefix":"10.1016","author":[{"given":"Konstantinos","family":"Porpodis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Tsiouprou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Bakakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigoris","family":"Stratakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyrios","family":"Tzouvelekis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschalis","family":"Steiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Katsoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kostikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina M.","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriana I.","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoletta","family":"Rovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Katsaounou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoleta","family":"Pastelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Tryfon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Fouka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tzanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios","family":"Loukides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-9108","authenticated-orcid":false,"given":"Kalliopi","family":"Domvri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.08.029_bib1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/all.16382","article-title":"Biologics and airway remodeling in asthma: early, late, and potential preventive effects","volume":"80","author":"Varricchi","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.08.029_bib2","article-title":"Targeting inflammation or remodeling in asthma? Is there a right way?","volume":"10","author":"Domvri","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2026.08.029_bib3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2737","article-title":"The airway epithelium in asthma","volume":"18","author":"Lambrecht","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2026.08.029_bib4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.08.029_bib5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaip.2024.01.023","article-title":"Phenotyping of severe asthma in the era of broad-acting anti-asthma biologics","volume":"12","author":"Bourdin","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.08.029_bib6","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.3390\/ijms26167692","article-title":"The role of endobronchial biopsies in evaluating biologic therapy response in severe asthma","volume":"26","author":"Bakakos","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2026.08.029_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/17476348.2025.2545571","article-title":"Mepolizumab for severe eosinophilic asthma","volume":"20","author":"Kallieri","year":"2026","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaci.2026.08.029_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2004.09.034","article-title":"Increased TGF-beta2 in severe asthma with eosinophilia","volume":"115","author":"Balzar","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.08.029_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaci.2024.10.024","article-title":"Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype","volume":"155","author":"Domvri","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.08.029_bib10","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jaci.2018.09.033","article-title":"Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma","volume":"143","author":"Khatri","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.08.029_bib11","first-page":"545","article-title":"Associated markers for adult-onset allergic asthma","volume":"14","author":"Bedolla-Barajas","year":"2015","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.08.029_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/jpm12030333","article-title":"Asthma with fixed airflow obstruction: from fixed to personalized approach","volume":"12","author":"Bakakos","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.jaci.2026.08.029_bib13","first-page":"356","article-title":"ERS\/ATS statement on interventional pulmonology. European Respiratory Society\/American Thoracic Society","volume":"19","author":"Bolliger","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2026.08.029_bib14","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","article-title":"An expert consensus framework for asthma remission as a treatment goal","volume":"145","author":"Menzies-Gow","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.08.029_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2500\/aap.2025.46.240084","article-title":"Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: a post-hoc analysis of RELIght study","volume":"46","author":"Papaioannou","year":"2025","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2026.08.029_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01313-2021","article-title":"Outcomes over the first two years of treatment with mepolizumab in severe asthma","volume":"58","author":"Elsey","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2026.08.029_bib17","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.mayocp.2021.04.025","article-title":"Eosinophils in health and disease: a state-of-the-art review","volume":"96","author":"Wechsler","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaci.2026.08.029_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1654111","article-title":"Mepolizumab treatment alters the functional phenotype of eosinophils in severe eosinophilic asthma","volume":"16","author":"Miguens-Suarez","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.08.029_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1465-9921-5-2","article-title":"Bronchospasm and its biophysical basis in airway smooth muscle","volume":"5","author":"Fredberg","year":"2004","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2026.08.029_bib20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.chest.2025.10.047","article-title":"Impact of mepolizumab on airway remodeling and inflammation in severe eosinophilic asthma","volume":"169","author":"Taille","year":"2026","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2026.08.029_bib21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1159\/000334701","article-title":"Effects of adding omalizumab, an anti-immunoglobulin E antibody, on airway wall thickening in asthma","volume":"83","author":"Hoshino","year":"2012","journal-title":"Respiration"},{"key":"10.1016\/j.jaci.2026.08.029_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/02770903.2019.1585872","article-title":"Omalizumab may decrease the thickness of the reticular basement membrane and fibronectin deposit in the bronchial mucosa of severe allergic asthmatics","volume":"57","author":"Zastrzezynska","year":"2020","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2026.08.029_bib23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI17974","article-title":"Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics","volume":"112","author":"Flood-Page","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.08.029_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00930-2019","article-title":"Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma","volume":"54","author":"Chachi","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2026.08.029_bib25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1159\/000530392","article-title":"Effect of benralizumab on mucus plugs in severe eosinophilic asthma","volume":"184","author":"Sakai","year":"2023","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2026.08.029_bib26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.alit.2024.02.002","article-title":"Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: a prospective, observational study","volume":"73","author":"Tajiri","year":"2024","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2026.08.029_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2023.11.879","article-title":"Evaluating the effect of dupilumab on type 2 airway inflammation and mucus plugging in patients with uncontrolled moderate-to-severe asthma: the VESTIGE trial","volume":"153","author":"Castro","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.08.029_bib28","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300135","article-title":"Tezepelumab and mucus plugs in patients with moderate-to-severe asthma","volume":"2","author":"Nordenmark","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jaci.2026.08.029_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01619-2023","article-title":"Airway remodelling in asthma and the epithelium: on the edge of a new era","volume":"63","author":"Varricchi","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2026.08.029_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1165\/rcmb.2024-0133OC","article-title":"Soluble E-cadherin contributes to airway inflammation in severe asthma","volume":"72","author":"Tang","year":"2025","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2026.08.029_bib31","first-page":"PA4609","article-title":"Mepolizumab reduces markers of airway remodelling in bronchial biopsies from patients with severe eosinophilic asthma after 6 months of treatment","volume":"66","author":"Drummond","year":"2025","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2026.08.029_bib32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2026.08.029_bib33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.08.029_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jot.2025.04.013","article-title":"Fibrocartilage hyalinization: a potential therapeutic strategy for articular fibrocartilage","volume":"52","author":"Li","year":"2025","journal-title":"J Orthop Translat"},{"key":"10.1016\/j.jaci.2026.08.029_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/ACI.0000000000000887","article-title":"Regulatory T-cells in asthma","volume":"23","author":"Harb","year":"2023","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.08.029_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13031","article-title":"Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab","volume":"94","author":"Bergantini","year":"2021","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaci.2026.08.029_bib37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1164\/rccm.202009-3631CI","article-title":"Severe adult asthmas: integrating clinical features, biology, and therapeutics to improve outcomes","volume":"203","author":"Wenzel","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2026.08.029_bib38","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/biomedicines12050960","article-title":"Evaluation of clinical remission in best-performing severe asthmatic patients treated for three years with mepolizumab","volume":"12","author":"Bagnasco","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaci.2026.08.029_bib39","first-page":"545","article-title":"Associated markers for adult-onset allergic asthma","volume":"14","author":"Bedolla-Barajas","year":"2015","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.08.029_bib40","series-title":"Global strategy for asthma management and prevention","year":"2019"},{"key":"10.1016\/j.jaci.2026.08.029_bib41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/jpm12030333","article-title":"Asthma with fixed airflow obstruction: from fixed to personalized approach","volume":"12","author":"Bakakos","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.jaci.2026.08.029_bib42","first-page":"356","article-title":"ERS\/ATS statement on interventional pulmonology. European Respiratory Society\/American Thoracic Society","volume":"19","author":"Bolliger","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2026.08.029_bib43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1183\/09031936.04.00063003","article-title":"Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma","volume":"24","author":"Elston","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2026.08.029_bib44","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jaci.2003.09.038","article-title":"Applying stereology to measure thickness of the basement membrane zone in bronchial biopsy specimens","volume":"112","author":"Ferrando","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.08.029_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2818.1979.tb00149.x","article-title":"Determination of membrane thickness distribution from orthogonal intercepts","volume":"115","author":"Jensen","year":"1979","journal-title":"J Microsc"},{"key":"10.1016\/j.jaci.2026.08.029_bib46","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1164\/rccm.2108069","article-title":"The relationship of reticular basement membrane thickness to airway wall remodeling in asthma","volume":"166","author":"James","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2026.08.029_bib47","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/resp.13360","article-title":"Inflammation-dependent and independent airway remodelling in asthma","volume":"23","author":"Elliot","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.jaci.2026.08.029_bib48","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1164\/rccm.201407-1374LE","article-title":"Reduction of airway smooth muscle mass by bronchial thermoplasty in patients with severe asthma","volume":"190","author":"Pretolani","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2026.08.029_bib49","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01507-2016","article-title":"Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling","volume":"49","author":"Berair","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2026.08.029_bib50","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1164\/rccm.201110-1849OC","article-title":"Airway smooth muscle hypertrophy and hyperplasia in asthma","volume":"185","author":"James","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2026.08.029_bib51","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4187\/respcare.01359","article-title":"Comparison of airway wall remodeling in asthma and COPD: biopsy findings","volume":"57","author":"Kosciuch","year":"2012","journal-title":"Respir Care"},{"key":"10.1016\/j.jaci.2026.08.029_bib52","first-page":"19","article-title":"E-cadherin downregulation at the infiltrating tumour front is associated with histologic grade and stage in colorectal carcinoma of Malaysians","volume":"37","author":"Dass","year":"2015","journal-title":"Malays J Pathol"},{"key":"10.1016\/j.jaci.2026.08.029_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2026.08.029_bib54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.12968\/hmed.2019.80.2.99","article-title":"Measurement of FeNO in asthma: what the hospital doctor needs to know","volume":"80","author":"Rupani","year":"2019","journal-title":"Br J Hosp Med (Lond)"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926006676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926006676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:23:06Z","timestamp":1793132586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926006676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"alternative-id":["S0091674926006676"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.08.029","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mepolizumab long-term remodeling effect in severe asthma responders: The MESILICO study","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}